National

09/14/2026 · Foley

FDA Approves New Pancreatic Cancer Drug Rasonque

The U.S. Food and Drug Administration approved Rasonque, a RAS inhibitor, for advanced pancreatic cancer. This decision provides a new treatment option for patients earlier than anticipated.

09/13/2026

Read Story

Health

FDA Authorizes First Device to Continuously Monitor Glucose and Ketones

The U.S. Food and Drug Administration has authorized the first wearable device that continuously monitors both ketone levels and blood sugar. The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System received approval for use by individuals aged two years and older living with diabetes.

09/13/2026

Politics

U.S. Imposes Sanctions on Organizations Designated as Threatening National Security

The United States has enacted sanctions against several organizations, including Autistici/Inventati, citing their alleged roles in providing support for or engaging in acts of violence. The measures block all U.S.-jurisdiction property and interests of the designated entities.

09/13/2026

Education

Consumers Face Compounding Financial Pressures Amid Rising Costs

Households already carrying debt now confront a new series of financial challenges. These include increased costs for back-to-school items, potential expenses from hurricane season, and ongoing essential pet care.

09/13/2026

Politics

U.S. Secretary Rubio Addresses ASEAN Conference, Discusses Iran and Regional Investments

Secretary of State Marco Rubio reiterated U.S. commitment to the ASEAN region at a conference in Manila. He announced $2.5 billion in U.S. government strategic investments and addressed the situation in the Middle East, specifically regarding Iran and the Strait of Hormuz.

09/11/2026

Entertainment

FDA Approves Viral Immunotherapy for Advanced Melanoma

The U.S. Food and Drug Administration granted accelerated approval to Tudriqev, a new viral immunotherapy. The treatment is for advanced melanoma that has not responded to other therapies. This genetically modified oncolytic virus represents a new option for patients.

09/11/2026